07:57 AM EDT, 05/23/2024 (MT Newswires) -- Guardant Health ( GH ) shares were temporarily halted on Thursday as a Food and Drug Administration panel prepared to meet to review the premarket approval application for the company's Shield blood test to screen for colorectal cancer.

Advisory committees provide independent expert advice and non-binding recommendations to the FDA, the company said.